Skip to content
WeighLab
Menu
Ranked #416 · Grade C

VigorMeds review

VigorMeds (Vigormeds LLC) is a provider-guided telehealth platform selling both injectable and needle-free sublingual compounded semaglutide ($139-$199/mo) and tirzepatide ($159-$299/mo).

Visit VigorMeds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (starting dose, compounded)
Tirzepatide
$299/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$3,588

Pricing verified August 2026

The Index scorecard

VigorMeds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month59/100
Price Transparency30/100
Nationwide Access24/100
Formulation Options77/100
Clinical Oversight78/100
Contract Flexibility41/100

Where the value is

  • Both injectable and needle-free sublingual forms of semaglutide ($139/mo) and tirzepatide ($159/mo) — the sublingual tier is $60-$140/mo cheaper than the injectable tier
  • Named, credentialed clinicians reviewing cases: Dr. Anthony Kane MD, Dr. Claudia Mondragon MD, Dr. Kevin Kargman MD, Stephanie Kowatch MSN FNP-C
  • 'Pay upon medical approval' — no charge until a provider signs off on treatment, plus a 30-day satisfaction guarantee
  • LegitScript approval seal and HIPAA-compliance badge both displayed on the site

The tradeoffs

  • The dedicated 'States We Serve' page names zero actual states in its crawlable content — only vague buckets like 'Coming soon' and 'Room to grow'
  • The FIRST100 promo code discounts whichever tier is chosen by $100 for the first month, so the price shown at signup is not the ongoing rate
  • No compounding pharmacy is named; prescribing is routed through OLA Health LLC and unnamed independent providers
  • No dose-tier breakdown beyond a single 'starting at' figure per format

The bottom line

Best for: Cost-first shoppers who want a needle-free sublingual GLP-1 that's meaningfully cheaper than the injectable version, from named physicians. VigorMeds (Vigormeds LLC) is a provider-guided telehealth platform selling both injectable and needle-free sublingual compounded semaglutide ($139-$199/mo) and tirzepatide ($159-$299/mo).

Ranked #416 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to VigorMeds.

The 24 programs nearest this one

Pricing, states and verification reflect VigorMeds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on VigorMeds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard